Clinic
Armstrong County Memorial Hospital
Armstrong County Memorial Hospital was paid $5.21M by Medicaid between Jan 2018 and Dec 2024, across 185 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.
33Billing provider infoARMSTRONG COUNTY MEMORIAL HOSPITAL
KITTANNING, PA 16201
KITTANNING, PA 16201
33aNPI1568577724assigned 08/20/2006
33bProvider typeClinic/Center
28Total paid$5.21M
24GClaims136,463
24DCodes billed185
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#31 of 176
Median peer was paid$441K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 436 | $6K | |
| 2019 | 167 | $3K | |
| 2020 | 10,765 | $431K | |
| 2021 | 69,043 | $2.61M | |
| 2022 | 17,054 | $837K | |
| 2023 | 22,095 | $718K | |
| 2024incomplete | 16,903 | $599K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 9,458 | 9,088 | $757K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 14% | 1,473 | 1,448 | $718K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 5,042 | 4,685 | $603K |
| 87631 | 12% | 4,003 | 3,939 | $599K | |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 7.2% | 7,363 | 5,337 | $374K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.4% | 3,479 | 3,423 | $230K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 4,510 | 4,385 | $167K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 1,669 | 1,623 | $144K |
| 80053 | Comprehensive metabolic panel | 2.4% | 10,640 | 9,614 | $127K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.8% | 630 | 588 | $95K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 3,093 | 2,915 | $94K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.7% | 1,289 | 1,272 | $89K |
173 more codes
| 80050 | General health panel | 1.5% | 1,637 | $78K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 10,613 | $64K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 306 | $57K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 593 | $52K |
| 80061 | Lipid panel | <1% | 3,513 | $51K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,752 | $40K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,815 | $37K |
| G0378 | Hospital observation service, per hour | <1% | 30 | $36K |
| 82248 | <1% | 4,907 | $34K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,007 | $31K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 368 | $30K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,855 | $29K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 452 | $29K |
| 0012A | <1% | 529 | $23K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 558 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 783 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 779 | $20K |
| 0002A | <1% | 397 | $17K | |
| 76830 | Ultrasound, transvaginal | <1% | 336 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 985 | $14K |
| 81001 | <1% | 4,592 | $14K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 161 | $13K |
| 85027 | <1% | 1,865 | $13K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 267 | $13K |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 326 | $13K |
| 0001A | <1% | 290 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,722 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,443 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,439 | $12K |
| 0011A | <1% | 291 | $12K | |
| 84703 | <1% | 1,089 | $12K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 254 | $11K |
| 84484 | <1% | 962 | $10K | |
| 87070 | <1% | 1,309 | $10K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 55 | $10K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 38 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 768 | $9K |
| 86618 | <1% | 317 | $8K | |
| 76801 | <1% | 195 | $8K | |
| 86780 | <1% | 488 | $8K | |
| 84702 | <1% | 441 | $8K | |
| 83735 | <1% | 1,104 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 256 | $7K |
| 87480 | <1% | 277 | $7K | |
| 84439 | <1% | 785 | $7K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 408 | $7K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 177 | $7K |
| 83880 | <1% | 181 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 297 | $6K |
| 97161 | <1% | 138 | $6K | |
| 87186 | <1% | 624 | $6K | |
| 93971 | <1% | 74 | $6K | |
| 83690 | <1% | 1,141 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 752 | $5K |
| 71250 | <1% | 92 | $5K | |
| 87077 | <1% | 587 | $5K | |
| 82728 | <1% | 367 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 322 | $4K |
| 87040 | <1% | 267 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 29 | $4K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 182 | $4K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 71 | $4K |
| 82043 | <1% | 464 | $4K | |
| 82607 | <1% | 290 | $4K | |
| 88164 | <1% | 474 | $4K | |
| 86762 | <1% | 169 | $4K | |
| 82565 | <1% | 568 | $4K | |
| 83540 | <1% | 407 | $4K | |
| 80076 | <1% | 371 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 49 | $3K |
| 84450 | <1% | 457 | $3K | |
| 84460 | <1% | 447 | $3K | |
| 86850 | <1% | 393 | $3K | |
| 73610 | <1% | 163 | $3K | |
| 87340 | <1% | 214 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $3K |
| 76642 | <1% | 73 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 38 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 59 | $3K |
| 83605 | <1% | 392 | $3K | |
| 87510 | <1% | 152 | $3K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 13 | $3K |
| 86039 | <1% | 160 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 64 | $3K |
| 0071A | <1% | 58 | $3K | |
| 84100 | <1% | 415 | $2K | |
| 0072A | <1% | 56 | $2K | |
| 85610 | <1% | 688 | $2K | |
| 85651 | <1% | 767 | $2K | |
| 86140 | <1% | 768 | $2K | |
| 84146 | <1% | 84 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 27 | $2K |
| 59025 | Fetal non-stress test | <1% | 347 | $2K |
| 85379 | <1% | 222 | $2K | |
| 73030 | <1% | 112 | $2K | |
| 84550 | <1% | 299 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 154 | $2K |
| 73630 | <1% | 150 | $2K | |
| 84153 | <1% | 74 | $2K | |
| 0064A | <1% | 43 | $2K | |
| 80051 | <1% | 268 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 100 | $2K |
| 85007 | <1% | 392 | $2K | |
| 86900 | <1% | 403 | $2K | |
| 83550 | <1% | 321 | $2K | |
| 87205 | <1% | 364 | $2K | |
| 86901 | <1% | 390 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 103 | $2K |
| 82947 | <1% | 389 | $2K | |
| 84520 | <1% | 296 | $2K | |
| 85730 | <1% | 215 | $2K | |
| 82784 | <1% | 102 | $2K | |
| 86617 | <1% | 33 | $1K | |
| 87075 | <1% | 134 | $1K | |
| 87522 | Neg quan hep c or qual rna | <1% | 31 | $1K |
| 87081 | <1% | 331 | $1K | |
| 84403 | <1% | 46 | $1K | |
| 94726 | <1% | 41 | $1K | |
| 86803 | <1% | 61 | $1K | |
| 73562 | <1% | 71 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 37 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 988 | $1K |
| 82746 | <1% | 93 | $1K | |
| 86431 | <1% | 139 | $1K | |
| 82570 | <1% | 144 | $1K | |
| 73130 | <1% | 88 | $1K | |
| 80164 | <1% | 53 | $1K | |
| 94729 | <1% | 29 | $1K | |
| 86317 | <1% | 43 | $953.85 | |
| 83970 | <1% | 22 | $939.25 | |
| 76641 | <1% | 15 | $860.09 | |
| 80178 | <1% | 105 | $827.71 | |
| 0004A | <1% | 20 | $824.00 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $778.85 |
| 84156 | <1% | 175 | $758.54 | |
| 94664 | <1% | 80 | $742.18 | |
| 76536 | <1% | 13 | $729.04 | |
| 95250 | <1% | 15 | $727.71 | |
| 83001 | <1% | 39 | $716.63 | |
| 84402 | <1% | 25 | $688.30 | |
| 72110 | <1% | 28 | $643.50 | |
| 77080 | <1% | 12 | $633.63 | |
| 96367 | <1% | 52 | $617.51 | |
| 87147 | <1% | 168 | $590.10 | |
| 74018 | <1% | 40 | $552.28 | |
| 88142 | <1% | 30 | $494.00 | |
| 82150 | <1% | 91 | $432.05 | |
| 82948 | <1% | 329 | $423.60 | |
| 81003 | <1% | 129 | $416.55 | |
| 83615 | <1% | 62 | $414.05 | |
| 82950 | <1% | 55 | $390.03 | |
| 72100 | <1% | 14 | $343.25 | |
| 84165 | <1% | 18 | $265.18 | |
| 82550 | <1% | 41 | $261.75 | |
| 82533 | <1% | 15 | $198.00 | |
| 73110 | <1% | 13 | $163.30 | |
| 84155 | <1% | 13 | $61.68 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 20 | $25.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 329 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,139 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 333 | $0.00 |
| A9270 | Non-covered item or service | 0% | 18 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,512 | $0.00 |
| J3490 | Unclassified drugs | 0% | 138 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 575 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 355 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 371 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 475 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 140 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 449 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 169 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 18 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGERACI, NICHOLE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Armstrong County Memorial Hospital | Kittanning, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.